Key terms
About PETS
PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company was founded in January 1996 and is headquartered in Delray Beach, FL.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest PETS news
Apr 15
9:30am ET
Analysts Are Bullish on These Healthcare Stocks: TELA Bio (TELA), Petmed Express (PETS)
Apr 15
8:21am ET
PetMed Express reports Q3 EPS (10c) vs (1c) last year
Mar 06
3:34pm ET
PetMed Express options imply 3.1% move in share price post-earnings
Feb 15
11:32am ET
PetMed Express Faces Nasdaq Compliance Challenge
Feb 15
8:34am ET
PetMed Express receives notice of non-compliance from Nasdaq
Feb 09
9:01am ET
Analysts Offer Insights on Healthcare Companies: Petmed Express (PETS), Dynatronics (DYNT) and Silk Road Medical (SILK)
Feb 09
8:44am ET
PetMed Express price target lowered to $9 from $13 at Lake Street
Feb 09
4:29am ET
Petmed Express Postpones Quarterly Report Submission
Feb 08
4:16pm ET
PetMed Express to restate previously issued financial statements
Feb 08
4:09pm ET
PetMed Express sees Q3 revenue $65.3M, one estimate $68M
Jan 29
2:19pm ET
PetMed Express options imply 11.3% move in share price post-earnings
No recent press releases are available for PETS
PETS Financials
Key terms
Ad Feedback
PETS Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
PETS Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
